A Review: Progress Against the Treatment of Ovarian Cancers

The American cancer society estimates the in 2013, 15,500 women will die of ovarian cancer in the United States. Women with ovarian cancers are living longer lives and have a betterquality of life as a result of advances in treatment and an improvedunderstanding of the disease. While chemotherapy once had an extremelymodest effect on ovarian cancer, today's treatments are much moreeffective at shrinking tumors and driving the disease intoremission, for all stages of the disease. Recent studies have shown thatovarian cancer is not one disease, but a spectrum of related diseaseswith unique genetic characteristics which may influence response totreatment. With these discoveries there is new potential to developpersonalized treatment regimens that are most effective and result infewer side effects. Most ovarian cancers respond well to initialchemotherapy, but the disease frequently reoccurs and more effectivedrugs are urgently needed to prevent and fight these recurrent tumors.New research offers reason for optimism. Cytoreductive surgery withHIPEC Hyperthermic Intra Peritoneal Chemotherapy is the latestintervention in the treatment of ovarian cancers. The goal of this surgery is to remove all the visible tumors, however, sometimes very small tumors and microscopic cancer cells are left behind and to prevent these cells from growing larger tumors in the abdomen the surgery is followed with HIPEC

Author(s): NehaTabassum, Mythri.G, Zeba Raheem, Dr. Azeez. S.A

Abstract | PDF

Share This Article